Abstract
Thrombolytic therapy is recommended for hemodynamically unstable patients with pulmonary embolism (PE). However, there is no consensus on whether thrombolytic therapy is beneficial for patients with submassive PE -- that is, PE with measurable hemodynamic effects that have not resulted in clinical instability. This double-blind, randomized German trial involved 256 patients with acute PE and …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
